Genenta Science S.P.A. - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Genenta Science S.P.A. - ADR
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
/ 
Others were interested in
Frequently asked questions
To buy Genenta Science S.P.A. - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Genenta Science S.P.A. - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Genenta Science S.P.A. - ADR is GNTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Genenta Science S.P.A. - ADR has its primary listing on NASDAQ (Small cap). You can trade Genenta Science S.P.A. - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Genenta Science S.P.A. - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Genenta Science S.P.A. - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Genenta Science S.P.A. - ADR or others.